Cargando…

Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect

Cystic fibrosis (CF) patients harboring the most common deletion mutation of the CF transmembrane conductance regulator (CFTR), F508del, are poor responders to potentiators of CFTR channel activity which can be used to treat a small subset of CF patients who genetically carry plasma membrane (PM)-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villella, Valeria Rachela, Esposito, Speranza, Bruscia, Emanuela M., Maiuri, Maria Chiara, Raia, Valeria, Kroemer, Guido, Maiuri, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549520/ https://www.ncbi.nlm.nih.gov/pubmed/23346057 http://dx.doi.org/10.3389/fphar.2013.00001

Ejemplares similares

Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis versus gluten-mediated inhibition in celiac disease
por: Maiuri, Luigi, et al.
Publicado: (2019)

Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis
por: Esposito, Speranza, et al.
Publicado: (2016)

The gliadin-CFTR connection: new perspectives for the treatment of celiac disease
por: Maiuri, Luigi, et al.
Publicado: (2019)

Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation
por: Stefano, Daniela De, et al.
Publicado: (2014)

Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation
por: Ferrari, Eleonora, et al.
Publicado: (2017)

Strategies for the etiological therapy of cystic fibrosis
por: Maiuri, Luigi, et al.
Publicado: (2017)

Defective proteostasis in celiac disease as a new therapeutic target
por: Maiuri, Luigi, et al.
Publicado: (2019)

Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease
por: Esposito, Speranza, et al.
Publicado: (2019)

Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis
por: Villella, Valeria R., et al.
Publicado: (2019)

Strategies to circumvent the CFTR defect in cystic fibrosis
por: Becq, Frédéric, et al.
Publicado: (2013)

The Multifaceted Roles of MicroRNAs in Cystic Fibrosis
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2020)

Molecular Chaperones as Targets to Circumvent the CFTR Defect in Cystic Fibrosis
por: Chanoux, Rebecca A., et al.
Publicado: (2012)

Autophagy delays progression of the two most frequent human monogenetic lethal diseases: cystic fibrosis and Wilson disease
por: Maiuri, Luigi, et al.
Publicado: (2018)

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
por: Tosco, A, et al.
Publicado: (2016)

The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis
por: Occhigrossi, Luca, et al.
Publicado: (2023)

Collective rotational motion of freely expanding T84 epithelial cell colonies
por: Ascione, Flora, et al.
Publicado: (2023)

Correction to: ‘Collective rotational motion of freely expanding T84 epithelial cell colonies’ (2023) by Ascione et al.
por: Ascione, Flora, et al.
Publicado: (2023)

Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR
por: Zhang, Shaoyi, et al.
Publicado: (2018)

A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease
por: Villella, Valeria R, et al.
Publicado: (2018)

Aspirin induces autophagy via inhibition of the acetyltransferase EP300
por: Castoldi, Francesca, et al.
Publicado: (2018)

Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study
por: Amato, Felice, et al.
Publicado: (2021)

Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
por: Jaganathan, Devi, et al.
Publicado: (2022)

Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy
por: Castoldi, Francesca, et al.
Publicado: (2018)

Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol
por: Morselli, Eugenia, et al.
Publicado: (2009)

L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
por: Lo Cicero, Stefania, et al.
Publicado: (2023)

Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fbrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
por: Lo Cicero, Stefania, et al.
Publicado: (2023)

Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi(®)) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells
por: Favia, Maria, et al.
Publicado: (2020)

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2019)

BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy
por: Pedro, Jose Manuel Bravo-San, et al.
Publicado: (2015)

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut
por: Renga, Giorgia, et al.
Publicado: (2018)

Defective autophagy gets to the brain
por: Galluzzi, Lorenzo, et al.
Publicado: (2015)

Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination
por: Kleinfelder, Karina, et al.
Publicado: (2023)

Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis
por: Piona, Claudia, et al.
Publicado: (2022)

A multifunctional, multi-pathway intracellular localization signal in Huntingtin
por: Desmond, Carly R., et al.
Publicado: (2013)

A Breathe in Cystic Fibrosis Therapy: A New Therapeutic Endeavor for Cysteamine
por: De Stefano, Daniela, et al.
Publicado: (2015)

Immuno-Sensing at Ultra-Low Concentration of TG2 Protein by Organic Electrochemical Transistors
por: Preziosi, Valentina, et al.
Publicado: (2023)

An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis
por: Di Lullo, A.M., et al.
Publicado: (2017)

Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
por: Petrazzuolo, Adriana, et al.
Publicado: (2022)

Mammary carcinoma: toward a realistic mouse model of incurable cancers
por: Pérez-Lanzón, Maria, et al.
Publicado: (2023)

Targeting the Heme Oxygenase 1/Carbon Monoxide Pathway to Resolve Lung Hyper-Inflammation and Restore a Regulated Immune Response in Cystic Fibrosis
por: Di Pietro, Caterina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4s7pq2q6hmrvetvhmaiijr19io